text:
Minister who objected to Morsi's hush hush meeting with Iran is ousted from government
Former Egyptian interior minister Ahmed Gamal al-Din was replaced in last week's Cabinet reshuffle after he objected to a meeting between an advisor to President Mohammed Morsi and a senior commander of the Iranian Islamic Revolutionary Guard, according to Egyptian media reports.
The low-profile meeting between the Iranian and Egyptian official focused on intelligence issues, including the development of Egypt's intelligence agency, the widely circulated al-Masry al-Youm newspaper reported, quoting sources.
Iran's Suleimani reportedly spoke about his experience in Iran's security affairs, and the Muslim Brotherhood officials who met with him expressed their desire to learn from the Iranian security experience.
The Times quoted a member of the Muslim Brotherhood's guidance office or Maktab al-Irshad as saying, "The government requested a high-level meeting with Iranian officials. Iran sent Suleimani."
"The meeting was intended to send a message to America, which is putting pressure on the Egyptian government, that we should be allowed to have other alliances with anyone we please," the official added.
The Muslim Brotherhood has denied such allegations; "Some newspaper and websites have quoted a British newspaper saying that the Muslim Brotherhood asked for secret Iranian support to strengthen their control over the country, and that some leaders met the head of the Iranian Quds Force earlier this year, but this news is fiction and totally untrue," said the media spokesman for the Brotherhood, Mahmoud Ghozlan.
Top Headlines
Sorry to say that if the story is correct, though I doubt it, it means the guy doesn't have a political sense. In light of the blatant UAE attack on Egypt, stretching a hand to Iran is a magnificent pressure against all the Gulf. Looking the other way round, Gamal was not successful at all in maintaining order, eradicating violence and ridding Egypt of the thugs who rule the street. REMOVING him is a well-played move at all levels.


text:
Section Title
120.310 Purpose and Scope
120.315 Definitions
120.320 Conditional Uses
120.325 Minimum Standards
120.330 Application for Conditional Use Permit
120.335 Preliminary Permit
120.340 Procedures
120.345 Issuance of Permits
120.350 Amendment to Conditional Use Permit
120.355 Coordination with Solid Waste Disposal Committee and Other Regulator Agencies
120.360 Standards for Solid Waste Disposal Site Rehabilitation and Restoration
120.365 Suspension or Revocation of Solid Waste Disposal Site Permit
120.370 Failure to Maintain Site or Conditions
120.375 Administration and Enforcement
120.380 Required Agreements and Liens
(a) To protect the health, safety and welfare of the people of Marion County and to provide a coordinated program for accumulation, storage and disposal of wastes and solid wastes, it is deemed essential to:
(1) Provide necessary sites for disposal of wastes and solid wastes;
(2) Provide for a coordinated solid waste disposal program and encourage regional solid waste disposal systems;
(3) Provide for coordinating zoning regulations with the Marion County Solid Waste Collection and Disposal Ordinance;
(4) Provide standards and procedures for reasonable protection of adjacent or nearby land uses;
(5) Provide for rehabilitation and ultimate site use for disposal sites after discontinuance of use for disposal;
(6) Provide for preliminary planning permit to allow initial consideration of disposal sites in coordination with other affected federal, state and local agencies;
(7) Provide for disposal sites and special regulations for accumulation, storage, or disposal of toxic or hazardous wastes.
(b) This Ordinance shall not apply to the growing or harvesting of crops or timber including, but not limited to, silvicultural practices or to agricultural operations conducted on premises owned or in possession of the person disposing of wastes or solid wastes on such premises.
(c) The intent and purpose of this section is to permit the location and development of solid waste disposal sites in appropriate locations in any zone in Marion County subject to the minimum standards herein set forth and any conditions established by the Commission or Hearings Officer, without a showing of hardship and after notice and public hearing as provided in Section 120.340.
Notwithstanding the allowable use in any other district in Marion County, any person initiating an operation as described in Sections 120.310 to 120.380.
120.315 DEFINITIONS. As used in Sections 120.310 to 120.380, unless the context requires otherwise, the following definitions shall apply:
(a) Dispose or Disposal. Includes accumulation, storage, collection transportation, and disposal of solid wastes;
(b) Person. Includes the State of Oregon, any individual, public or private corporation, political subdivision, governmental agency, municipality, industry, co-partnership, association, firm, trust, estate, or any other legal entity whatsoever.
(c) Solid Waste. All putrescible and nonputrescible wastes, whether in a solid or in a liquid form, except liquid-carried industrial wastes or sewage or sewage hauled as an incidental part of a septic tank or cesspool cleaning service, but including garbage, rubbish, ashes, sewage sludge, street refuse, industrial wastes, swill demolition and construction wastes, abandoned vehicles or parts thereof, tires, discarded home and industrial appliances, manure, vegetable or animal solid or semi-solid wastes, dead animals and other discarded solid materials;
(d) Solid Waste Disposal Site or Sites. Any land used for disposal of solid wastes, including, but not limited to, dumps, landfills, sanitary landfills, incinerators, and composting plants, but not including a landfill site which is not used by the public either directly or through a disposal service and which is used by the owner or tenant thereof to dispose of sawdust, bark, soil, rock, building demolition material or nonputrescible industrial waste products resulting from the process of manufacturing;
(e) Waste. Useless, unwanted or discarded materials.
120.320 CONDITIONAL USES. The following uses may be permitted as conditional uses within all zoning districts by the Commission or Hearings Officer, notwithstanding the use limitations of each zone, subject to the conditions and procedural requirements set forth in Sections 120.310 to 120.380.
(a) Solid Waste Disposal Site;
(b) Except within the EFU-20 zone, sites for the disposal of special materials or hazardous wastes when, and only after the Planning Commission or Hearings Officer has approved the special materials for inclusion in the site;
(c) A residence for a caretaker;
(d) Buildings, structure, apparatus or other appurtenances necessary for these uses to be carried on.
120.325 MINIMUM STANDARDS. The following minimum standards shall apply to the establishment, maintenance, and operation of solid waste disposal sites within Marion County. The particular concerns of these provisions are providing for an adequate number of solid waste disposal sites to meet the needs of Marion County and the proper location of solid waste disposal sites including access to and from the sites, the appearance of such sites as they relate to the surrounding area and for the ultimate reuse of such sites.
(a) Screening. The site shall be reasonably screened from adjoining developing properties and public streets or highways by placement of landscaped yards and areas adjacent to every property line, within which yard or area will be placed an ornamental fence, wall or hedge or landscape berm. This shall be in addition to such desirable vegetation as may exist within the landscaped area. Where the landowner or the holder of a franchise for the site has obtained an interest in adjacent property for the purpose of providing adequate screening or where an appropriate governmental agency provides for such screening, the Commission or Hearings Officer may accept such screening in lieu of that otherwise required by this subsection. This screening, whether on the same or other property, shall continuously obscure the view of the site and the landowner or franchise holder shall be responsible for maintenance of such screening.
(b) Access Roads. All access to the site shall be by a route or routes approved by the County Engineer, Hearings Officer and the Commission.
(c) Control of Operation Time. Except for such activities as office machinery repair and the equivalent, in residential, farm or commercial districts, a limit shall be placed on the operating time from 4:30 a.m. to 9:30 p.m. This limitation on operating time may be waived by the County Engineer in times of public or private emergency for the duration of such emergency. Other activities may be conducted outside the allowable time limit if they fall within standards established for industrial uses as set forth in Section 150.140.
120.330 APPLICATION FOR CONDITIONAL USE PERMIT. Application by the landowner shall be made to the Commission or Hearings Officer on forms furnished by the Planning Division. Each application shall be accompanied by:
(a) An accurate plot plan showing exterior boundaries of the property on which the disposal site is to be located and the location of any existing or proposed structures, roads, proposed operating areas or other improvements, and the topography of the proposed site;
(b) A certified list of property owners in the affected area in the same manner as is set forth in Section 123.050.
(c) A plan for rehabilitation and use of the site after the disposal has been terminated for a use permitted within the zone in which the land is located. Such a plan shall be prepared at a scale of not less than 1" = 400' with topographic contours, an interval of which shall not be less than 25 feet. In its discretion, the Commission or Hearings Officer may require a map or plan showing greater detail to determine compliance with this Ordinance and standards established by the Commission or Hearings Officer.
(d) A copy of the application to the Governing Body of Marion County for a franchise pursuant to the Solid Waste Collection and Disposal Ordinance if the site is to be owned or to be operated by a person other than a governmental agency.
(e) An agreement required by Section 120.380 of this Ordinance.
(f) Except for applicants who have previously paid for a preliminary permit on the same site, a fee of $25.00.
(a) In view of the extensive investigations which must be undertaken in coordination with federal, state and local agencies, persons desiring to obtain a solid waste disposal site conditional use permit may make application to the Commission or Hearings Officer and the Commission or Hearings Officer may grant preliminary approval of a proposed site without notice to interested persons or a public hearing.
(b) The Commission or Hearings Officer shall consider the location, the general proposal for access and site operation, the need for the site, the needs of the area, and the proposed restoration and rehabilitation of the site. The Commission or Hearings Officer shall review the application as soon as possible after the petition has been filed. The granting of a preliminary permit is not binding either on the Commission, Hearings Officer or on the applicant but is given to the applicant only as a guide. A conditional use permit application may be filed pursuant to Section 120.330 regardless of the recommendation of the Commission or Hearings Officer pursuant to this Section.
(c) Each application for a preliminary permit shall be on forms furnished by the Planning Division and shall be accompanied by a fee of $25.00. The preliminary permit application may be withdrawn at any time; however, the $25.00 fee shall not be returned. The application shall be accompanied by any franchise application as required pursuant to Section 120.330 for a conditional use permit.
(d) Test wells, test holes, or any other engineering tests may be conducted under a preliminary permit.
(e) Except for existing solid waste disposal sites that qualify as nonconforming uses, no person holding a preliminary permit therefore shall establish, operate or maintain a solid waste disposal site unless and until a conditional use permit has been issued by the Commission or Hearings Officer.
(a) Notice and public hearing upon an application for a conditional use permitted under Section 120.320 shall be the same as provided for variances in Section 122.050 except that, in addition, notice shall be given to property owners within the affected area as provided in Section 123.060 for zone changes.
(b) Notice of the decision of the Commission or Hearings Officer shall be given as provided in Section 122.060.
(c) Decisions of the Commission or Hearings Officer on conditional use applications under Section 120.320 shall be subject to the certification and appeal procedures and other provisions provided in Sections 122.070 to 122.140 inclusive.
(a) The Commission or Hearings Officer shall make such investigations as are necessary to determine whether the proposed site conforms fully to the regulations set forth herein.
(b) In addition to the requirements of Sections 120.310 to 120.380, the Commission or Hearings Officer may prescribe additional restrictions or limitations when granting a preliminary permit or a conditional use permit for a proposed site. The Commission or Hearings Officer may prescribe such additional conditions as it deems necessary to fulfill the purpose and intent of this Ordinance after finding that such conditions are necessary for the public health, safety, general welfare or to protect persons working or residing in the area, or to protect property or improvements in the area, or to protect the aesthetic qualities of the area, or to protect the environmental quality of the area.
(c) The Commission or Hearings Officer may not reduce or change the requirements specified in Sections 120.310 to 120.380 except when proceedings have been held for variance of these requirements by the Commission or Hearings Officer pursuant to Section 17, provided that an application for variance may be filed with an considered concurrently with the conditional use application, except that the notice of hearing shall separately state the variance applied for.
120.350 AMENDMENT TO CONDITIONAL USE PERMIT. When the conditional use permit holder wishes to amend the plans for the site or for the restoration or reuse of such site after a final permit has been granted, he shall make an application for such change and shall furnish a fee of $25.00 together with all information and agreements that would have been required had such change been included in the initial plans, information and agreements submitted to the Commission or Hearings Officer. The Commission or Hearings Officer shall follow the same procedure for notice and hearing as if the amendment were a new application for such a conditional use. The notice and hearing shall be limited to the subject of a requested change in plans.
120.355 COORDINATION WITH THE SOLID WASTE DISPOSAL COMMITTEE AND OTHER REGULATORY AGENCIES. The Commission or Hearings Officer will make every effort to assist in the coordination and review of the application with the Marion County Solid Waste Committee and all federal, state, local or other agencies.
(a) The purpose of this section is to insure the future use of a site after its use as a solid waste disposal site has been completed. A restoration plan shall be consistent with the land use planning policies and ordinances of Marion County.
(b) The landowner and the holder of any franchise to operate the site shall be jointly and severally liable for the eventual site restoration as described in the plans submitted with the permit application as provided in Section 120.380.
(c) Upon completion of the use of the site for solid waste disposal according to the permit and plan, or upon economic abandonment of the site as a disposal site, the landowner and the holder of any franchise to operate the site shall have a reasonable time to rehabilitate and restore the site as described in the restoration plans.
(d) Except for buildings or structures which are permitted uses in the zone in which the site is located, upon termination of the use of the site for solid waste disposal, all buildings, equipment, apparatus and appurtenances necessary to the operation shall be removed from the site unless an extension is granted by the Commission or Hearings Officer. A grant of additional time by the Commission or Hearings Officer shall not excuse any delay in the restoration or rehabilitation of those portions of the property under permit which are not affected by such extension.
(e) All excavations and pits shall be backfilled, leveled, contoured, or both, for the uses shown on the restoration plan and shall be compatible with the final depth and slope of the site.
(f) Top soil shall be replaced to sufficient depth to allow landscaping material to be installed.
(g) When appropriate, the Commission or Hearings Officer may specify a schedule of rehabilitation for portions of the property as their use for solid waste disposal operations is completed or terminated. The schedule shall be considered part of the rehabilitation or restoration plan and shall be included in the agreements required by Section 120.380.
(a) In addition to the provisions of Section 122.140, the Commission or Hearings Officer may, after a public hearing, at which all interested persons have a right and opportunity to be heard, suspend a solid waste disposal site permit for failure to comply with Sections 120.310 to 120.380 or other applicable provisions. Prior to such hearing, the Commission or Hearings Officer shall obtain a recommendation from the Marion County Solid Waste Committee. Before any action of suspension is finally ordered by the Commission or Hearings Officer, the Commission or Hearings Officer shall obtain the concurrence of the Governing Body.
(b) The Commission or Hearings Officer may, following the same procedures specified in (a) of this section, revoke a solid waste disposal site permit for failure to comply with Sections 120.310 to 120.380 or other applicable provisions. The Commission or Hearings Officer shall make a finding prior to revocation that there is an immediate and serious danger to the public, an immediate and serious threat or actual pollution of air, water or surrounding land or other serious hazard or public nuisance.
120.370 FAILURE TO MAINTAIN SITE OR CONDITIONS. The landowner, as the holder of a conditional use permit, and the holder of any franchise to operate the site, shall establish, operate, and maintain the site within the terms and conditions set forth in Sections 120.310 to 120.380 and in the conditional use permit. Compliance with this section shall be a condition to a conditional use permit and shall be enforceable by the agreement required in Section 120.380.
120.375 ADMINISTRATION AND ENFORCEMENT. It shall be the duty of the County Building Official, County Health Officer, and County Engineer to enforce Sections 120.310 to 120.380. Prior to issuance of a preliminary permit or of a conditional use permit, prior to establishment of any site and during the operation, maintenance or restoration or rehabilitation of such site pursuant to Sections 120.310 to 120.380, it shall be the duty of said officials to determine compliance with those sections and with any condition imposed by the Commission or Hearings Officer. For this purpose, the County Engineer, County Health Officer or County Building Official, or their duly authorized representatives may enter upon public or private property to perform any such duty. In addition to the right of entry specified by this section, the landowner as holder of the conditional use permit and the holder of any franchise to operate the site shall agree to this right of entry as provided in Section 120.380.
(a) The Governing Body finds and declares that a properly established, maintained, operated, and rehabilitated solid waste disposal site is a utility facility necessary for public service and, as such, is a valuable asset in improving environmental quality of the County. The Board further finds and declares that an improperly established, operated, maintained, or rehabilitated site may become a public or private nuisance, produce a condition of unsightliness, establish a health hazard or otherwise create a condition detrimental to the environmental quality of the area and of the County. To implement these findings, the Governing Body further finds and declares that it is necessary and appropriate to require agreements from the landowners who apply for a conditional use permit the agreements required by this section and further finds and declares that the appropriate remedy to reimburse costs of the County incurred in enforcement of Sections 120.310 to 120.380 is, upon failure of the landowner or franchise holder to pay such costs, the imposition of lien against the premises.
(b) On forms issued by the Planning Division, the landowner who is applying for a conditional use permit for a site pursuant to Sections 120.310 to 120.380 and the holder of any franchise to operate such site, shall jointly and severally agree to accept, to be responsible for or to be liable for:
(1) The entry upon subject premises by named officials pursuant to Section 120.375.
(2) Proper establishment, maintenance, and operation of the site as required by Section 120.370.
(3) Rehabilitation and restoration of the site upon termination for use as a disposal site pursuant to Section 120.360.
(c) In the event the landowner or the franchise holder does not comply with his agreement executed pursuant to subsection (b) of this section and within a reasonable time after written notice to comply, the Governing Body may institute proceedings under subsection (d) of the section to enforce compliance. "Reasonable time" within this subsection shall be determined by the Commission or Hearings Officer upon the basis of the health, safety, and welfare of the people of Marion County and of the area and in determining what is a reasonable time, the Commission or Hearings Officer may give consideration to, but shall not be limited by the following:
(1) The nature of the deficiency;
(2) Conditions created by the deficiency;
(3) Hazard to health or safety;
(4) The creation of a condition of unsightliness;
(5) The creation of a public or private nuisance;
(6) Whether there is a satisfactory alternative practice, procedure or operation.
(d) In the event that the landowner or franchise holder fails to comply with the order of the Commission or Hearings Officer within the time specified by the Commission or Hearings Officer, the Commission or Hearings shall notify the Marion County Governing Body. The Governing Body may institute proceedings for enforcement by giving 30 days written notice to the landowner or franchise holder, or both, at their last known addresses. The Board may shorten the notice period to not less than 24 hours notice if the Governing body finds an immediate or serious danger to the public through the creation of a health hazard or a pubic or private nuisance. After required notice, the Governing Body may hold a public to be heard. After such public hearing and on the basis thereof, the governing Body shall have the power to order appropriate county agencies to correct and deficiencies in the establishment, maintenance or operation of the site, or to make the required rehabilitation and restoration.
(e) The cost incurred by the County in carrying out subsection (d) of this section shall be paid by the landowner or the franchise holder or both. If not paid, the Governing Body may order appropriate action to be taken to impose a lien upon the subject premises.
(f) The Commission or Hearings Officer may order the filing in the County Deed Records of the conditional use permit including the agreements executed pursuant to this section as a recorded encumbrance or the real property to assure compliance with the conditions and agreements.

subset: commoncrawl


text:
Beth A. Jones PhD, MPH
Research Scientist in and Lecturer in Epidemiology (Chronic Diseases)
Biographical Info
Dr. Jones is a cancer epidemiologist whose work and teaching focus is on health disparities. Her research is focused on racial/ethnic differences in cancer screening and cancer outcomes. Current studies include predictors of mammography screening and other health behaviors, the impact of circular migration on cancer screening, and colorectal cancer screening in Hispanic/Latinas living in the Northeast, US. She serves as a consultant on a molecular profiling study of breast cancer diagnosed in women in central and South America. Using a multidisciplinary approach, she has evaluated the role(s) of tumor characteristics, selected genetic alterations and genetic polymorphisms, as well as social class, medical care, and psychosocial factors, in explaining differences cancer stage at diagnosis and survival between African Americans and Whites in breast, prostate, and colorectal cancer. Other work has identified important African American/White differences in mammography screening and screening outcomes.
Education & Training
- Yale School of Public Health (1986)
- Ph.D.
- Yale University (1993)
Honors & Recognition
- Co-Chair, Health Disparities Committee, CT Cancer Partnership
- Member, Board of Directors
Community Health Action, Innovation and Networking, Inc. (CHAIN) (2008-present)
- Co-Director, Office of the Elimination of Cancer Disparities, Yale Comprehensive Cancer Center
- State of Connecticut Yale Comprehensive Cancer Center Breast Cancer Research Award
- American Cancer Society Travel Award
Professional Service
- Co-Director, Office of the Elimination of Cancer Disparities, Yale Comprehensive Cancer Center (2006 - 2008)
- Co-Chair, Health Disparities Committee, CT Cancer Partnership (2006 - 2008)
- Invited Testimony/Presenter, President's Council on Cancer (01/01/2009)
- Charter Memeber, CT Multicultural Health Partnership, State of CT Dept of Public Health (01/01/2008)


text:
The Lannisters seem very underpowered in this game. In a 4 player game, the Greyjoys can make an easy early attack to take the Riverrun Stronghold and there isnt much the Lannisters can do about it. The Lannisters are then playing catchup to try and take that crucial stronghold back, basically killing themselves and the Greyjoys in the process. Meanwhile, the Starks can take an easy time gobbling up the North and hit Seagard and Riverrun at their leisure. All the while, the Baratheons basically have the entire south to themselves. With a mere 3 ships, they can hit all 7 castles they need and win the game before anyone can even reach them. This setup seems seriously flawed.
Also, the stats for the Jaime Lannister card are completely ridiculous. Strength 2 and 1 sword?!? He is weaker than the majority of the cards in the game!! Was this meant to be his stats after his hand was hacked off!? It doesnt feel like the person who put the stats on that card read a single page in Song of Ice and Fire. Even after just a few games, we have had to use house rules to better balance this travesty. We gave Jaime a skull to offset his stupid numbers and basically everyone bum rushes the Baratheons in the beginning just so we all have a fighting chance. I was really hoping for a better experience with this game.


text:
Quick Links
New Study Aims to Understand Long-term Effects of Diabetes Medications
The National Institutes of Health (NIH) is looking for volunteers to take part in a study to compare the long-term benefits of four widely used diabetes drugs in combination with metformin, the most common first-line medication for treating type 2 diabetes. The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) launched the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE) in June 2013. The researchers hope to recruit 5,000 participants at 37 sites.
The goal of this large trial is to understand which combinations of medications are most likely to maintain goal glucose (blood sugar) levels over time, to identify the most effective means of treating type 2 diabetes if metformin alone is not enough. The study will compare drug effects on glucose levels, adverse effects, diabetes complications, and quality of life over an average of nearly 5 years. The researchers hope to be better able to guide physicians as they make treatment decisions for their patients with diabetes.
Large NIH Study to Examine if Vitamin D Prevents Type 2 Diabetes
Researchers have begun the first definitive, large-scale clinical trial to investigate if a vitamin D supplement helps prevent or delay type 2 diabetes in adults who have prediabetes, a condition that puts them at risk for developing type 2.
The multiyear Vitamin D and Type 2 Diabetes (D2d) study will include about 2,500 people at 20 study sites across the United States. Its goal is to learn if vitamin D—specifically D3 (cholecalciferol)—will prevent or delay type 2 diabetes in adults age 30 or older with prediabetes. People with prediabetes have blood glucose levels that are higher than normal but not high enough to be called diabetes.
Researchers are recruiting volunteers to take part in D2d. Half of the participants will receive vitamin D. The other half will receive a placebo—a pill that contains no medication. Participants will have check-ups for the study twice a year, and will receive regular health care through their own health care providers.
"An estimated 79 million Americans have prediabetes, and nearly 26 million more have diabetes," said NIDDK Director Griffin P. Rodgers, M.D., M.A.C.P. "With D2d, we seek evidence for an affordable and accessible way to help prevent or delay type 2 diabetes."
New and Updated Publications
- Gestational Diabetes: What You Need to Know
- Prevent diabetes problems: Keep your kidneys healthy
- Prevent diabetes problems: Keep your kidneys healthy (Spanish)
- What I need to know about Gestational Diabetes
- What I need to know about Gestational Diabetes (Spanish)
- What I need to know about Preparing for Pregnancy if I Have Diabetes
Recent Issues
NIH Awards Human Microbiome Project Phase II Grants
To better understand how and why alteration of the normal microbiome at various body sites promotes diseases, the National Institutes of Health (NIH) will fund three innovative research projects for the next 3 years. These projects constitute the second phase of the Human Microbiome Project (HMP), begun in 2007. The first phase of the HMP focused on the composition and genetic potential of the microbial communities of major regions of the body and how these communities differ in health and for various diseases.
Second-phase research teams will use genomics and other "omics" technologies to measure the biochemical activities of these microbial communities. Researchers hope to determine how microbes influence the physiology of the human host within which they reside.
One joint project will examine the microbes in the gut and nose and determine how alteration in certain microorganisms may trigger the development of diseases such as diabetes. A second joint project will assess the populations and physiological activities of gut microbes in people with Crohn's disease and ulcerative colitis. The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) will manage these grants.
A third project will study bacteria that live in the vagina and assess the roles these bacteria play in health and disease in pregnant women as well as in their babies, particularly for preterm birth. The Eunice Kennedy Shriver National Institute of Child Health and Human Development will manage this grant.
Tips for Finding Reliable Health Information Online
Finding accurate, reliable, and current health information online can be difficult and overwhelming. The Internet has a wealth of health information—some information is true and accurate, and some is not.
Here are a few things to keep in mind when visiting a website:
Several Government resources offer additional tips when searching for online health information:
New and Updated Publications
Late September
NIH-funded Study Finding: Lifestyle Intervention Does Not Lower Heart Disease Risk from Type 2 Diabetes
The Look AHEAD (Action for Health in Diabetes) study found that an intensive diet and exercise program resulting in weight loss does not reduce cardiovascular events such as heart attack and stroke in people with longstanding type 2 diabetes.
The study, supported by the National Institutes of Health (NIH), tested whether a lifestyle intervention resulting in weight loss would reduce rates of heart disease, stroke, and cardiovascular-related deaths in overweight and obese people with type 2 diabetes, a group at increased risk for these events. Researchers compared the intensive lifestyle intervention with a general intervention of diabetes support and education. The study includes 5,145 participants at 16 centers across the United States. The intervention was stopped after up to 11 years of follow-up because participants in both the intervention and control arms had similar rates of cardiovascular disease events.
Participants in the lifestyle intervention were able to lose weight and sustain much of that weight loss throughout the study. They lost over 8 percent of their initial body weight at 1 year and 6 percent at the time the study ended, compared with less than 1 percent and 3.5 percent of those in the diabetes support and education group. Although the lifestyle intervention did not reduce rates of cardiovascular events, it has shown a number of health benefits, including improving sleep apnea, reducing the need for diabetes medications, improving quality of life, and helping to maintain physical mobility.
Researchers will continue to follow long-term outcomes of all Look AHEAD participants.
NIH-funded Study Finding: CABG Has Advantages over PCI in Adults with Diabetes and Multivessel Coronary Heart Disease
Adults with diabetes and multivessel coronary heart disease who underwent coronary artery bypass graft (CABG) surgery had fewer adverse events and better survival rates than those who received percutaneous coronary intervention (PCI) with drug-eluding stents. The 5-year study, funded by the NIH, included 1,900 participants.
"The advantages of CABG over PCI were striking in this trial and could change treatment recommendations for thousands of individuals with diabetes and heart disease," said principal investigator Valentin Fuster, M.D., Ph.D.
New and Updated Publications
Early September
Dr. Thomas E. Starzl Wins 2012 Lasker Award
Dr. Thomas E. Starzl, the first person to perform a human liver transplant, received the 2012 Lasker-DeBakey Clinical Medical Research Award—shared with Dr. Roy Calne, University of Cambridge emeritus—on September 21, 2012, for his work in developing liver transplantation. Dr. Starzl is a distinguished service professor of surgery at the University of Pittsburgh School of Medicine and longtime National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) grantee. He has also served on the NIDDK Digestive Diseases Advisory Board.
"Dr. Starzl is a pioneer in the world of transplantation, and his work has saved thousands of lives," said NIDDK Director Griffin P. Rodgers, M.D., M.A.C.P. "This award is a most fitting recognition of his many years of unwavering commitment to teaching, research, and clinical practice."
2012 Nobel Prize in Chemistry Awarded to Two NIH Grantees
The 2012 Nobel Prize in chemistry was awarded jointly to National Institutes of Health (NIH) grantees Robert J. Lefkowitz, M.D., of the Howard Hughes Medical Institute and Duke University Medical Center, and Brian K. Kobilka, M.D., of the Stanford University School of Medicine, for groundbreaking discoveries on G-protein-coupled receptors. Dr. Lefkowitz has received support from the National Heart, Lung, and Blood Institute (NHLBI) since 1974. Dr. Kobilka has received support from the NHLBI, the National Institute of Neurological Disorders and Stroke, the National Institute of General Medical Sciences, and the National Institute on Drug Abuse since 1990.
"NIH is proud to have supported this work, which began as basic science and ultimately led to dramatic medical advances," said NIH Director Francis S. Collins, M.D., Ph.D.
Many of these advances are relevant to the mission of the NIDDK since hormones that act through these receptors regulate key endocrine and gastrointestinal functions.
Late August
NIH-funded Study Finding: Frequency and Severity of Retinopathy in Type 1 Diabetes is Decreasing
Two National Institutes of Health (NIH)-funded, population-based studies in the same geographic region looked at the frequency and severity of diabetic eye disease after 20 years of diabetes. A group of 305 subjects from the Wisconsin Diabetes Registry Study (WDRS) received retinal examinations from 2007 to 2011. A group of 583 subjects from the Wisconsin Epidemiological Study of Diabetes Retinopathy (WESDR) received retinal examinations from 1980 to 1996. Researchers found that the frequency and severity of diabetic retinopathy was lower for individuals in the WDRS group compared with those in the WESDR group.
The researchers suggest that more intensive insulin management and diabetes care in recent years appears to have changed the retinopathy prognosis for people with type 1 diabetes. After the Diabetes Control and Complications Trial's 1993 finding that intensive glucose control was effective in slowing the onset and progression of eye, kidney, and nerve damage, improved health is now evident in people with diabetes as a result of intensive glucose control.
Following people who were enrolled in two population-based studies provided a unique opportunity to compare outcomes of individuals with type 1 diabetes over time. Researchers noted that updated projections should be used when informing newly diagnosed individuals of prognosis and when assessing health care cost.
Study Finding: Prepregnancy Overweight and Obesity Contribute to the Prevalence of LGA Infants
Researchers have found that women with prepregnancy overweight and obesity account for a high proportion of large-for-gestational-age (LGA) infants compared with women of normal weight—even in those who do not develop gestational diabetes mellitus (GDM). Having an LGA infant increases the risk of shoulder injury to the newborn during childbirth. Birth by cesarean section is also more likely to occur with an LGA infant.
The researchers conducted a retrospective study of 9,835 women who delivered at 20 or more weeks' gestation; had a prenatal 2-hour, 75-g oral glucose tolerance test; and were not treated with diet, exercise, or antidiabetic medications during pregnancy. The women were categorized into six mutually exclusive prepregnancy groups: normal weight with and without GDM, overweight with and without GDM, and obese with and without GDM. Study data suggest that prepregnancy overweight and obesity substantially contribute to the prevalence of LGA infants, as well as other adverse outcomes, in women who never develop GDM. The combination of being overweight or obese and having GDM increased the odds of having an LGA infant even more. Increasing gestational weight gain was associated with a higher prevalence of LGA infants in all groups.
Researchers suggest that interventions that effectively help overweight or obese women lose weight before pregnancy and/or control weight gain during pregnancy, regardless of GDM status, have the potential to reach far more women at risk for having an LGA infant and other adverse outcomes. The Lifestyle Interventions in Expectant Moms study, or LIFE-Moms, conducted by the NIH, is testing several lifestyle interventions to control weight gain in pregnant women who are overweight or obese.
Early August
Panel Supports Maintaining the Current Diagnostic Approach for Gestational Diabetes Mellitus
An independent panel convened March 4–5 by the National Institutes of Health (NIH) has concluded that despite potential advantages of adopting a new diagnostic approach for gestational diabetes mellitus (GDM), more evidence is needed to ensure that the benefits outweigh the harms. The panel recommended following the current diagnostic approach until further studies are conducted.
"The panel believes that cost-benefit, cost-effectiveness, and cost-utility research is needed to more fully understand the implications of changing diagnostic protocols for GDM," said Dr. Peter VanDorsten, M.D., conference panel chairperson and Lawrence L. Hester, Jr. Professor, Medical University of South Carolina, Charleston.
NIH-funded Study Finding: After Gestational Diabetes, Women Can Lower Type 2 Diabetes Risk
By sticking to a healthy diet in the years after pregnancy, women who develop diabetes during pregnancy can greatly reduce their risk of developing type 2 diabetes, a study supported by the NIH has found. The risk of developing type 2 diabetes increases greatly in women who have had gestational diabetes compared with women who have not had gestational diabetes.
Women who followed one of three designated diets closely in the years following gestational diabetes reduced their risk of diabetes by about half compared with women who did not follow one of the diets. The study is the first to show that the risk of type 2 diabetes in this population can be reduced solely through dietary intervention.
NIH Launches Study of Long-term Effects of Blood Glucose during Pregnancy
Researchers funded by the NIH plan to determine whether elevated blood sugar during pregnancy, a less severe condition than gestational diabetes, influences later levels of body fat in children and development of diabetes in mothers after giving birth. The original study, the Hyperglycemia and Adverse Pregnancy Outcomes (HAPO), looked at 23,316 mother-child pairs and found that a mother's blood sugar levels, even short of diabetes, were associated with her newborn's birth weight and body fat.
The HAPO-Follow-up Study (HAPO-FUS) seeks to recruit 7,000 of the original HAPO mother-child pairs for a single visit to one of 10 of the original HAPO clinical centers. Mothers and children (now ages 8 to 12 years) will have their height, weight, blood pressure, body fat, blood sugar, insulin, and blood fats measured.
Study Finds Lower Death Rates for People with Diabetes
Death rates for people with diabetes—especially due to heart disease and stroke—dropped significantly from 1997 to 2006. Although rates of heart disease and stroke are declining for all U.S. adults, researchers at the National Institutes of Health (NIH) and the Centers for Disease Control and Prevention (CDC) found that the rates are dropping faster for adults with diabetes compared with those without diabetes. Recent CDC studies also found declining rates of kidney failure, lower extremity amputations, and hospitalization for heart disease and stroke among people with diabetes.
Improved medical management of diabetes and heart disease contributed to the decline, as well as prevention efforts such as the National Diabetes Education Program, a joint effort of the CDC and the NIH, and the National Diabetes Prevention Program, a public-private partnership led by the CDC.
NIH Study Shows Big Improvement in Diabetes Control over Past Decades
More people are meeting recommended goals in the three key markers of diabetes control, according to a study conducted and funded by the NIH and the CDC. The measures are A1C—which assesses blood sugar (glucose) over the previous three months—blood pressure and cholesterol.
The report, published online in Diabetes Care, shows that, from 1988 to 2010, the number of people with diabetes able to meet or exceed all three of the measures that demonstrate good diabetes management rose from about 2 percent to about 19 percent. Each measure also showed substantial improvement, with over half of people meeting each individual goal in 2010.
Despite improvement, the results show continued need for better diabetes control. In particular, young people and some minority groups were below average in meeting the goals.
Researchers Induce Beta Cell Gene Expression in Pancreatic Alpha Cells
Researchers treating human and mouse cells with compounds that modify cell nuclear material called chromatin have induced the expression of beta cell genes in pancreatic alpha cells.
Diabetes is caused by insufficient numbers of insulin-producing beta cells. Recent studies have noted that alpha cell production of excess glucagon, which elevates blood glucose, is an important feature of diabetes etiology.
The researchers believe that reprogramming alpha cells into beta cells may one day offer a path to cell replacement therapies for type 2 diabetes. Results of the study, funded by the National Institute of Diabetes and Digestive and Kidney Diseases, were published online March 1 in The Journal of Clinical Investigation.
"This would be a win-win situation for diabetics—they would have more insulin-producing beta cells and there would be fewer glucagon-producing alpha cells," says lead author Klaus H. Kaestner, Ph.D., professor of Genetics and member of the Institute of Diabetes, Obesity and Metabolism, Perelman School of Medicine, University of Pennsylvania.
New and Updated Publications
Late April
New Diabetes Materials Available for Health Care Instructors, Consumers
Be Active When You Have Diabetes, a new booklet and instructor's guide, helps people with diabetes learn about the health benefits of being physically active and ways to increase their activity level. The very easy-to-read booklet, written at a second- to third-grade reading level, contains tools to help consumers create and manage a physical activity plan, record target goals, and track their activities.
Be Active When You Have Diabetes: A Guide for Instructors is the companion instructor's guide developed for use in one-on-one or small group patient education. The flipbook provides color illustrations and simple teaching points on the corresponding instructor pages. The booklet and instructor's guide, from the National Institute of Diabetes and Digestive and Kidney Diseases' (NIDDK's) National Diabetes Information Clearinghouse (NDIC), include a list of resources from the NDIC, the National Diabetes Education Program, the NIDDK Weight-control Information Network, and the National Institute on Aging.
NIH Collaborates with India on Diabetes Research Effort
The National Institutes of Health (NIH) is partnering with the Indian Council of Medical Research to collaborate on diabetes research and ways to improve prevention and treatment. The U.S. Department of Health and Human Services signed a joint statement with India's Health and Family Welfare Minister to begin a formal research relationship.
"Both the United States and India have a vested interest in improving our understanding of and treatment for diabetes, and in finding economical ways to do both," said NIDDK Director Griffin P. Rodgers, M.D., M.A.C.P. "Initiating this research relationship will enable both countries to share expertise and engage each other in research to lessen the burden of diabetes—in the U.S., India, and around the world." The NIDDK will lead the U.S. role in the collaboration.
In February 2013, the NIDDK and the Indian Council of Medical Research held a scientific workshop to identify opportunities for collaboration between the two countries in high-priority diabetes research areas of joint interest. A summary of the workshop can be found in the recent NIDDK Director's Update.
NIDDK Seeks Director for the Type 2 Diabetes Prevention Program
The NIDDK is looking for a talented and experienced program officer (medical officer) to serve in the Division of Diabetes, Endocrinology, and Metabolic Diseases (DEM) as director of the Type 2 Diabetes Prevention Program and as a senior scientific advisor to the NIDDK for human subject research in type 2 diabetes. The incumbent would be responsible for the scientific and administrative management of a portfolio that may include multicenter and single-site clinical studies, and for the development of joint research activities with other government organizations.
An appropriate applicant must possess an M.D. or equivalent degree, and expertise in endocrinology, internal medicine, or another specialty relevant to diabetes. Strong candidates should have conducted independent research, and be able to demonstrate the knowledge and insight needed to identify important scientific opportunities in diabetes research and to participate in the design of clinical trials or observational studies. Experience in translational research is also desirable.
The NIDDK Medical Officer vacancy announcement for this position will be posted April 5–16, 2013, at www.jobs.nih.gov/. Search for announcement number NIH-NIDDK-DH-15-855001 in the "Search for NIH Jobs" box.
For questions or information about this and upcoming position openings in DEM for talented medical officers (M.D.) to manage clinical studies and program directors (M.D. or Ph.D.) to help move basic research discoveries toward disease prevention and treatment, please contact DEM Director Dr. Judith Fradkin at email@example.com.
Find other exciting new job opportunities at the NIDDK! Check back often to view vacancies, updated regularly, as positions are advertised for 5–10 days. For more information, go to: www2.niddk.nih.gov/AboutNIDDK/NIDDKJobOpportunities/.
NIDDK, NIH, and DHHS are equal opportunity employers.
New and Updated Publications
Early April
2013 Edition of NIDDK's Annual Scientific Report Now Available
The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) annual scientific report, NIDDK Recent Advances & Emerging Opportunities, is now available. This report highlights examples of NIDDK-supported research advances published in fiscal year 2012. It also includes stories of discovery, which trace research progress in specific areas over an extended time frame; profiles patients who are living with diseases that are part of NIDDK's research mission; and highlights scientific presentations made to the NIDDK's National Advisory Council during the past year.
The report also contains an overview of NIDDK research training programs; information on the HBO documentary series "The Weight of the Nation"—a collaborative public awareness campaign showing how obesity affects the country's health; and a feature on the 2012 Lasker award winner in basic research, long-time NIDDK grantee Dr. Thomas E. Starzl, a pioneer in the field of liver transplantation.
To read the report, go to www.niddk.nih.gov. Or request a hard copy via the message box at http://catalog.niddk.nih.gov/ContactUs.cfm, by calling 1–800–860–8747 between 8:30 a.m. and 5 p.m. EST on Monday through Friday, or by writing to NIDDK Clearinghouses Publications Catalog, 5 Information Way, Bethesda, MD 20892–3568.
New NIH Resources Help Growing Number of Americans with Vision Loss
A large-print booklet and a series of videos to help people adapt to life with low vision are available from the National Eye Institute (NEI), a part of the National Institutes of Health (NIH). The chief causes of vision loss in older people are age-related macular degeneration, diabetic retinopathy, cataract, and glaucoma. The materials were released during Low Vision Awareness Month, February 2013.
The booklet, Living with Low Vision: What you should know, urges people with low vision to seek help from a low vision specialist and provides tips to maximize remaining eyesight, enabling them to safely enjoy a productive and rewarding life. The videos feature patient stories about living with low vision. Another video, targeted to health care professionals, emphasizes the importance of informing patients with vision loss about vision rehabilitation services. The booklet and the videos were developed by the NEI National Eye Health Education Program.
"I encourage anyone with low vision to seek guidance about vision rehabilitation from a low vision specialist," said NEI Director Paul A. Sieving, M.D., Ph.D. "For many people, vision rehabilitation can improve daily living and overall quality of life."


text:
Prices shown in currencies other than USA Dollars are estimates based on current exchange rates. We will charge your credit card in USA Dollars on the day your order is shipped, and the conversion to your local currency will be done at the prevailing rate by your credit card issuer.
Shipments outside the USA are declared as "bike parts" for customs purposes and will include the actual amount paid for merchandise and shipping. Jenson USA will not mark your parcel as a "gift", declare a value lower than the actual price paid, or otherwise prepare false customs information.
Tell a friend! We'll send your friends the page and your message.
Note: You and your friend's email addresses are only used once as a referral. We will not collect or store the email addresses.
Lezyne was founded on March 1, 2007 by an industry icon by the name of Micki Kozuschekand his partners. Lezyne's goal was to engineer and produce premium quality accessories that meet the same high standards as high- end bicycle components. Since 2007, Lezyne has increased their product line, and has maintained their high standards.
The Lezyne RAP 20 multitool is lightweight, strong, and compact enough to pack with you in your saddle bag. The RAP tool line was designed as Lezyne's entry- level tools, however they do not lack in quality. Forged and drawn CrV bits are nickel plated for durability. Wrapped Center Pivot bits increase tool rigidity and improve ergonomics.
Jenson USA ships worldwide, including APO/FPO addresses. For a quote, simply add the items you are interested in to your shopping cart and look for the "Shipping Options" box. You don't have to login or create an account to see shipping charges.
Some manufacturers restrict where we can ship their products. If this item has shipping restrictions, they are listed below. If you'd like to buy an item that we cannot ship to your preferred address, we can accept your foreign credit card and ship to a USA address for you.
Get free shipping with your $50 purchase today when you choose Standard Shipping at checkout. Please note this offer is only available to physical shipping addresses in the 48 continental United States (no PO Boxes), and oversize charges still apply on some heavy/large items
Get free Standard Shipping with your $50 purchase today! Just choose Standard Shipping during checkout.
Please note this offer is only available to physical shipping addresses in the 48 continental United States (no PO Boxes), and oversize charges still apply on some heavy/large items.


text:
Asthma: Over The Counter Treatment Center - Bell Gardens, CA
Bell Gardens Asthma & Allergy Specialist Doctors for Asthma: Over The Counter Treatment
Type of Physician: Asthma & Allergy Specialist
What is a Asthma & Allergy Specialist?
A certification by the Board of Allergy & Immunology; practitioners are expert in the evaluation, diagnosis and management of immune disorders.
Specialty: Allergy, Asthma & Immunology
Common Name: Allergy Doctor
Asthma & Allergy Specialist Doctors in Bell Gardens *
Burger & Nguyen MDs
Burger & Nguyen MDs
Cavales Allergy/Asthma Med
Alan O Khadavi MD
Pioneer Medical Group
Allergy Asthma Sinusitis Specs
Allergy Asthma Sinusitis Specs
White Memorial Pediatrics
Allergy & Immunology Center
Allergy & Immunology Center
LAUSC Pediatrics
Allergy & Immunology Center
Allergy & Immunology Center
Allergy & Immunology Center
Allergy & Immunology Center
Allergy & Immunology Center
Pacific Allrgy/Asthma Mdcl Assc
Mosaic Family Care Med Grp
Adult & Child Allergy & Asthma
Eugene Tsai MD
Yu L Hsu MD
Harold C Ochsner Jr MD
Allergy & Asthma Care Center SC
Allergy & Asthma Care Center SC
Allergy & Asthma Care Center SC
Allergy & Asthma Care Center SC
Allergy & Asthma Care Center SC
Engemann Student Health Center
Engemann Student Health Center
Allergy Medical Group
Allergy Medical Group
Horacio G Lopez MD
Allergy Asthma/Respiratory Cr
Allergy Asthma/Respiratory Cr
Miller Childrens Hosp Pediatric
Talbert Medical Group
Miller Childrens Hosp Pediatric
Janet Kim MD
Preventive Health Clinical Svc
Huntington Medical Foundation
Huntington Asthma/Allergy Ctr
Frederick Ho MD PC
Frederick Ho MD PC
Frederick Ho MD PC
John H Smith Jr MD
Joseph Medical Group
S & J Medical Group
Allergy&Asthma Care Specialists
Allergy&Asthma Care Specialists
Charles K Oh MD
San Gabriel Valley Allergy Grp
Robert M Plancey MD Inc
Timothy A Pham Medical Corp
Ray E Williams MD
Allergy Asthma Respiratory Care
Children's Hosp Allrgy Immnlgy
Children's Hosp Allrgy Immnlgy
Satish S Gupta MD
Primax Healthcare
Thomas J Tsou MD
Allergy & Asthma Clinics
Allergy & Asthma Clinics
Kaiser South Bay Medical Center
Charles E Groncy MD
Kaiser South Bay Medical Center
Douglas B Tamkin MD
Allergy & Asthma Care
Allergy & Asthma Care
Keiichiro Omori MD
South Bay Allergy/Asthma Assocs
South Bay Allergy/Asthma Assocs
South Bay Allergy/Asthma Assocs
South Bay Allergy/Asthma Assocs
Alan R Green MD
Allergy & Asthma Associates
Allergy & Asthma Associates
Allan D Singer MD
Joshua M Davidson MD
Ghodsi Madani MD Inc
Allan D Singer MD
Family Allergy & Asthma Med Ctr
Galant & Lin MDs Inc
Huang & Huang Mds
Galant & Lin MDs Inc
Robert W Eitches MD
Robert W Eitches MD
Song Institute Of Allrgy Asthm
Song Institute Of Allrgy Asthm
Healthcare Partners Medical Grp
Stuart Z Epstein MD
Kaiser Permanente Medical Group
Robert F Meth MD
Riviera Allergy Medical Center
Allergy Asthma/Sinus Medical
Allergy Asthma/Sinus Medical
Allergy Asthma/Sinus Medical
Dat M Nguyen MD
Allergy Medical Clinic Inc
Allergy Medical Clinic Inc
Allergy Medical Clinic Inc
Bell Gardens, California
Asthma: Over the Counter Treatment
What is asthma?
The cause of asthma is unknown. More is known about the abnormal conditions that occur in asthma. These conditions include:
Other Related Asthma: Over The Counter Treatment Articles
Emergency Contact for Bell Gardens
Nearby Bell Gardens Hospitals *
Downey Regional Medical Center
Rancho Los Amigos Hospital
Kaiser Permanente Medical Ctr
Los Angeles Community Hospital
St Francis Medical Center
Beverly Hospital
East Los Angeles Doctors Hosp
Community Hospital Huntngtn Prk
Coast Plaza Hospital
Lapaz At Paramount
Metropolitan State Hospital
Monterey Park Hospital
Promise Hospital Of East LA
Presbyterian Intercommunity
Promise Hospital
Norwalk Community Hospital
College Hospital Cerritos
Bellflower Medical Center
White Memorial Medical Center
Garfield Medical Center
Kedren Community Mental Health
LAC USC Medical Center
Keck Hospital Of USC
USC Kenneth Norris Cancer Ctr
La Casa Mental Health Center
Silver Lake Medical Center
Lakewood Regional Medical Ctr
Los Angeles Sheriff's Dept Med
California Hospital Medical Ctr
Whittier Hospital & Medical Ctr
Greater El Monte Community Hosp
Pacific Alliance Medical Center
Alhambra Hospital Medical Ctr
Kindred Hospital La Mirada
Kaiser Mental Health Center
Good Samaritan Hospital
Barlow Respiratory Hospital
BHC Alhambra Hospital
Silver Lake Medical Center
San Gabriel Valley Medical Ctr
St Vincent Medical Center
Memorial Hospital Of Gardena
Kindred Hospital South Bay
Gateways Hsptl & Mntl Hlth
Tri-City Regional Medical CT
Los Angeles Metropolitan Med
Shriners Hospital For Children
La Palma Intercommunity Hosp
Temple Community Hospital
Anaheim General Hospital
Long Beach Memorial Medical Ctr
Miller Children's Hosp Lng Bch
Centinela Hospital Medical Ctr
Pacific Hospital Of Long Beach
Kaiser Permanente Medical Ctr
Huntington Memorial Hospital
Childrens Hospitals Los Angeles
Hollywood Presbyterian Med Ctr
Kaiser Permnte Ls Angls Med Ctr
Los Angeles Metropolitn Med Ctr
Los Alamitos Medical Center
Community Hospital Long Beach
Aurora Las Encinas Hospital
Harbor UCLA Medical Center
Glendale Memorial Hospital
Redgate Mem Recvry Ctr
Kindred Hospital-Los Angeles
Methodist Hospital Southern CA
St Mary Medical Center
Anaheim General Hospital
Citrus Valley Medical Center
Glendale Adventist Medical Ctr
West Anaheim Medical Center
Hollywood Community Hospital
VA Long Beach Healthcare
*Provider Directory Terms of Use:
The WebMD 'Provider Directory' is provided by WebMD for use by the general public as a quick reference of information about Providers. The Provider Directory is not intended as a tool for verifying the credentials, qualifications, or abilities of any Provider contained therein. Inclusion in the Provider Directory does not imply recommendation or endorsement nor does omission in the Provider Directory imply WebMD disapproval.


text:
noun li·cense \ˈlī-sən(t)s\
: an official document, card, etc., that gives you permission to do, use, or have something
: freedom to act however you want to
: the freedom of an artist, writer, etc., to change the way something is described or shown in order to produce a work of art
Full Definition of LICENSE
a : permission to actb : freedom of action
a : a permission granted by competent authority to engage in a business or occupation or in an activity otherwise unlawfulb : a document, plate, or tag evidencing a license grantedc : a grant by the holder of a copyright or patent to another of any of the rights embodied in the copyright or patent short of an assignment of all rights
a : freedom that allows or is used with irresponsibilityb : disregard for standards of personal conduct : licentiousness
: deviation from fact, form, or rule by an artist or writer for the sake of the effect gained
— licensed adjective
See license defined for kids
Variants of LICENSE
li·cense or li·cence \ˈlī-sən(t)s\
Examples of LICENSE
- The restaurant's owner applied for a license to sell liquor.
- His job as a reporter gives him license to go anywhere and ask anything.
Origin of LICENSE
Middle English, from Anglo-French licence, from Latin licentia, from licent-, licens, present participle of licēre to be permitted
First Known Use: 14th century
Related to LICENSE
- Synonyms
- allowance, authorization, clearance, concurrence, consent, granting, green light, leave, permission (or licence), sanction, sufferance, warrant
- Antonyms
- interdiction, prohibition, proscription
See Synonym Discussion at freedom
Other Business Terms
: to give official permission to (someone or something) to do or use something : to give a license to (someone or something)
: to give official permission for (something)
: to allow the use of (a name, property, etc.) through a formal agreement
li·censed also li·cencedli·cens·ing also li·cenc·ing
Full Definition of LICENSE
transitive verb
a : to issue a license tob : to permit or authorize especially by formal license
: to give permission or consent to : allow
— li·cens·able \-sən(t)-sə-bəl\ adjective
— li·cen·sor \-sər, ˌli-sən-ˈsȯr\ also li·cens·er \-sər\ noun
Variants of LICENSE
license also licence
Examples of LICENSE
- The restaurant has now been licensed to sell liquor.
- a new drug licensed by the government
- The company licensed its name to others.
First Known Use of LICENSE
15th century
noun li·cense (Medical Dictionary)
Medical Definition of LICENSE
: a permission granted by competent authority to engage in a business or occupation or in an activity otherwise unlawful <a license to practice medicine>
—license or chiefly British licence transitive verb, li·censed or chiefly British li·cenced li·cens·ing or chiefly British li·cenc·ing
Variants of LICENSE
li·cense or chiefly British li·cence \ˈlīs-ən(t)s\
Learn More About LICENSE
Next Word in the Dictionary: license bondPrevious Word in the Dictionary: liceAll Words Near: license
Ask The Editor Videos
Seen & Heard
What made you want to look up license? Please tell us where you read or heard it (including the quote, if possible).


text:
Don't Have an Account? Join the IHG® Rewards Club
Redeem when you want, for what you want.
Reward Nights
When redeeming points for a Reward Night, you may only book one room at a time.
Once you complete your Reward Night reservation you will be given the option to duplicate this reservation.
* Requires affiliation in the respective organization.
** Best Available Rate Search does not include affiliation rates.
To book more than 9 rooms for one stay or request a quote, please use our Easy Meetings tool, call 1-800-MEETING (in United States, Mexico and Canada) or contact a Global Sales Office.
The leafy grounds of Holiday Inn Gloucester-Cheltenham are just 2 miles from junction 11a of the M5 motorway. We're a 45-minute drive from Birmingham Airport, and have plenty of complimentary parking. Trains leave for Cardiff and London from Gloucester rail station, 3 miles away, and the town of Cheltenham is 10 miles away.
View More
Holiday Inn Gloucester-Cheltenham is steps from the C&G offices, and 200 metres from EDF Energy. The government's GCHQ building is 5 miles away, and you can invite colleagues to our 8 air-conditioned meeting rooms, with wireless Internet and a relaxing breakout area.
Medieval stained glass adorns Gloucester Cathedral, 2 miles away, and you can bargain-hunt at Gloucester Quays' chic designer outlet. In only 10 minutes you can be strolling by the River Windrush and exploring pretty Cotswolds villages. Cheltenham, with its smart boutiques and programme of festivals, is 10 miles away.
Pamper yourself at Holiday Inn Gloucester-Cheltenham's Spirit Health Club with hot stone massages, pedicures and laps of the pool. Bright and airy Traders Restaurant prepares a hot breakfast buffet and modern brasserie cuisine. Your under-12s stay and eat free when sharing a room with their parents.
Best Price Guarantee
We promise you access to the guaranteed best available prices, or your first night is free.
Online Reservation Guarantee
Your room is guaranteed.
No Booking Fees!
We do not charge any booking fees for making reservations directly with us.
Data Privacy and Site Security
IHG takes your privacy seriously and works to protect you. All personal information you provide is encrypted and secure.
About IHG
IHG Careers
IHG Global Brands
Explore Hotels
Email Management
Terms of Use
Privacy Statement
Site Map
Cookie Usage
Learn more about our free apps.
Top Destinations
Atlanta Hotels | Chicago Hotels | Dallas Hotels | Honolulu Hotels | Houston Hotels | Los Angeles Hotels | New York Hotels | Orlando Hotels | San Francisco Hotels | Washington DC Hotels | Las Vegas Hotels | New Orleans Hotels | London Hotels | Paris Hotels | Dubai Hotels | Sydney Hotels | Hong Kong Hotels | Amsterdam Hotels | Toronto Hotels | Shanghai Hotels | IHG Travel Blog
© 2015 IHG. All rights reserved. Most hotels are independently owned and operated.
The standard cookie policy for this website is to allow all cookies. This helps to ensure you have the optimal experience. If you would like to continue with our optimal website experience, you don't need to make any changes. If you would like to learn more about how we use cookies or change your settings, you can use the link at the bottom of any page at any time.